2409 days ago
With its shares having reached 25.75p last week and closed at above 25p on Wednesday, Amryt Pharma (AMYT) announced on Thursday that it was “delighted with the support we have received” for an “oversubscribed placing”, raising a gross €15 million (£13.3 million)… at 20p per share! As a long standing shareholder I say "F**k you." I feel so utterly 100% shafted as will those who paid 26p+ last week after confident results which made it clear that Amryt was fully funded. So I asked Steve Moore to pen an analysis. As I explained in Thursday's bearcast HERE I am too angry to be objective. The fact is that at a 22.5p offer the shares are a BUY.
2409 days ago
I am a shareholder in Amryt (AMYT) which has had a placing today. I am furious and feel shafted. The shares are almost certainly cheap but I feel livid so am off, with Joshua, for coffees with the fit young mums. I also comment on i3 Energy (TOAST), 88 Energy (88E), Frontera (FRR) and ADVFN (AFN).
2579 days ago
There seems to be a lot happening and as a result this bearcast comes to you from Shipston. I will head back to London later tonight and hope to see you all at UK Investor Show tomorrow. Pro tem I comment on Corero (CNS), Minoan (MIN), Amryt (AMYT) and Wishbone (WSBN) - we own the last two on that list and are very happy to do so. I also comment on allegations made elsewhere by the "share blogger of the year."
2590 days ago
Shore cap is House broker to Amryt Pharma (AMYT) so everything it writes cannot be said to be any way shape or form impartial. And since we own a shed load of the shares we are biased as hell too. Having said that this note is detailed and lifting the target price from 35p to 88p in light of recent news is pretty dramatic given that the shares were 18.5p on Friday when this "most excellent" research note came out.
